PAVmed (PAVM) EBIAT (2022 - 2025)
Historic EBIAT for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$6.0 million.
- PAVmed's EBIAT changed N/A to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $39.8 million for FY2024, which is 15020.12% up from last year.
- Per PAVmed's latest filing, its EBIAT stood at -$6.0 million for Q3 2025.
- PAVmed's 5-year EBIAT high stood at $19.0 million for Q1 2025, and its period low was -$29.9 million during Q3 2022.
- For the 4-year period, PAVmed's EBIAT averaged around -$15.3 million, with its median value being -$18.2 million (2023).
- Per our database at Business Quant, PAVmed's EBIAT tumbled by 1314.62% in 2023 and then surged by 20246.33% in 2025.
- Quarter analysis of 4 years shows PAVmed's EBIAT stood at -$24.6 million in 2022, then rose by 29.16% to -$17.4 million in 2023, then surged by 108.22% to $1.4 million in 2024, then crashed by 520.06% to -$6.0 million in 2025.
- Its last three reported values are -$6.0 million in Q3 2025, -$12.3 million for Q2 2025, and $19.0 million during Q1 2025.